From the category archives:

Swine Flu Treatment

Researchers develop “last defence” treatment against swine flu

Hong Kong researchers have developed a treatment for people infected by swine flu using the antibodies from blood plasma from patients who recovered from the disease, a media report said Thursday. According to the study, 30 critically ill patients in Hong Kong were given the treatment after they failed to respond to antiviral drugs Tamilflu [...]

Read the full article →

Enrolling Pregnant Women in Research – Lessons from the H1N1 Influenza Pandemic

The global H1N1 influenza pandemic disproportionately affected pregnant women, drawing attention to the fact that although they need safe and effective medical treatment, they have always been a marginalized study population. Antiviral agents for treating influenza have been available in the United States for more than 10 years and are widely prescribed for pregnant women. [...]

Read the full article →

Swine flu lung plan ‘should remain’

A specialist treatment used to help critically ill swine flu patients should continue to be provided at UK level, a report has recommended.An expert group has examined whether Scotland should have its own centre for extracorporeal membrane oxygenation ECMO treatment, when oxygen is given to patients whose heart or lungs do not function properly. via [...]

Read the full article →

PLoS Medicine: Public Health Challenges of the H1N1 Flu Pandemic

# As the global epidemiology of the pandemic (H1N1) 2009 influenza (H1N1pdm) virus strain unfolds into 2010, substantial policy challenges will continue to present themselves for the next 12 to 18 months. # Here, we anticipate six public health challenges and identify data that are required for public health decision making: Measuring age-specific immunity to [...]

Read the full article →

Cure for all types of flu could be on the way

What the researchers have discovered is the existence of a small-viral RNA (svRNA), produced by the virus, that is vital to the switch from one state to the other. If they can find a way of thwarting this svRNA, then the RNA segments won’t be able to proceed to replication, and the virus will be [...]

Read the full article →

Gold nanorods deliver potent payload to attack H1N1

The paper describes the single-strand RNA molecule, which prompts a strong immune response against the influenza virus by ramping up the host’s cellular production of interferons, proteins that inhibit viral replication. But, like most RNA molecules, they are unstable when delivered into cells. The gold nanorods produced at UB act as an efficient vehicle to [...]

Read the full article →

Swine flu vaccine cost lower but medical care high

SWINE flu has cost Wales £35m, according to new figures. The figure is well below the pre-determined worst-case prediction of £80m, which was drawn up before the outbreak’s scale became clear. But the actual cost could rise as high as £60m, as a contingency fund earmarked for the flu pandemic was used to ease NHS [...]

Read the full article →

Seaweed for treatment of swine flu?

In a groundbreaking new discovery a Tasmanian company has used seaweed as treatment for swine flu. The lab trials have been going on for the past nine months using the undaria seaweed (better know as wakame seaweed) harvested from waters at Triabunna, of Tasmania's East Coast. This development was announced by Tasmanian scientist Helen Fitton [...]

Read the full article →

Swine flu – ventilators are major cost

HOSPITAL chiefs have developed an action plan if the swine flu pandemic returns after learning lessons from the outbreak. Bosses spent £318,876 on managing the pandemic in the year up to April. The largest proportion of that (£181,000) was spent on ventilators in clinical care. The Pandemic Operational Planning Team (POPT) which managed the pandemic [...]

Read the full article →

Triple Combination Anti Flu Drug Being Trialled

The study conducted by investigators at the Fred Hutchinson Cancer Research Center in Seattle, Washington, and Seattle Children's Hospital, was a randomized, open-label study of TCAD therapy (amantadine and ribavirin administered with oseltamivir) versus oseltamivir monotherapy in immunocompromised patients with Influenza A. The objective of the study was to assess the safety, tolerability, and virologic [...]

Read the full article →

← Previous Entries